Both in Biotechnology
Outlook Therapeutics vs Armata Pharmaceuticals
Over the past year OTLK returned −64.6% and ARMP returned −36.0%; their daily moves had a correlation of -0.00.
OTLK −64.6% ARMP −36.0%Growth of $1, one year, split-adjusted
| Metric | OTLK | ARMP |
|---|---|---|
| Price | $0.4600 | $3.09 |
| Market cap | $112.0M | $114.9M |
| Today | −1.96% | +8.42% |
| 1 month | −22.8% | −15.6% |
| 6 months | +90.3% | −67.0% |
| Year to date | −70.9% | −50.8% |
| 1 year | −63.5% | −37.1% |
| Revenue growth (YoY) | −99.4% | +15.7% |
| Gross margin | −95.0% | 100.0% |
| Net margin | −233554.9% | 2953.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 20.7× |
| Net cash | -$7.0M | -$259.6M |
| Dividend yield | — | — |
| Volatility (60d) | 89.0% | 115.8% |
| Short % of float | 39.3% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).